Condition
Signs and Symptoms clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Signs and Symptoms clinical trials that are recruiting, at sites in 5 countries (most in Denmark (1), Canada (1), Latvia (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Signs and Symptoms clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Turning anonymous symptom descriptions into structured biological signals with OpenGenome | — | Friedrichshain, State of Berlin | Recruiting | May 11, 2026 |
| Selective activation of the adrenomedullin receptor to provoke migraine in adults with migraine without aura | — | Glostrup Municipality | Recruiting | Mar 5, 2026 |
| Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions | — | Washington D.C., District of Columbia and 2 other locations | Recruiting | Dec 2, 2025 |
| Effects of Dexmedetomidine on cognitive recovery after cardiac surgery | Phase 4 | Vancouver, British Columbia and 7 other locations | Recruiting | Feb 28, 2020 |
All recruiting trials (4)
-
Turning anonymous symptom descriptions into structured biological signals with OpenGenome
This project tries to turn adults' anonymous free-text symptom descriptions submitted to OpenGenome into structured, literature-grounded biological signals using PubMed and ClinicalTrials.gov sources and a constrained reasoning model.
-
Selective activation of the adrenomedullin receptor to provoke migraine in adults with migraine without aura
This study tests whether selectively activating the adrenomedullin receptor can trigger migraine attacks in adults who have migraine without aura, after blocking CGRP receptors.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
Effects of Dexmedetomidine on cognitive recovery after cardiac surgery
This study is testing if a medication called Dexmedetomidine can help people recover their thinking skills better after having heart surgery.
Related topics
Quick answers
How many Signs and Symptoms clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Denmark (1 trial), Canada (1 trial), Latvia (1 trial), United States (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.